ResearcherYonsei UniversityNo recent work listed
Joo Won Chung
Matched on ORCID iD 0000-0003-1572-8056; OpenAlex author ID A5032004597. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2011: 1 paper · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper
Papers 3
- Assessment of the Risk of Colorectal Cancer Survivors Developing a Second Primary Pancreatic Cancer. Co-author DOI 10.5009/gnl16526↗
- Folfox4 as a rescue chemotherapy for gemcitabine-refractory pancreatic cancer. Co-author PMID 23858557↗
- Proteomic analysis of pancreatic juice for the identification of biomarkers of pancreatic cancer. Co-author DOI 10.1007/s00432-011-0992-2↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Seung Woo Park · 3 shared papers, 2011–2017 · strength 0.14
- Paper Assessment of the Risk of Colorectal Cancer Survivors Developing a Second Primary Pancreatic Cancer. DOI 10.5009/gnl16526↗
- Paper Folfox4 as a rescue chemotherapy for gemcitabine-refractory pancreatic cancer. PMID 23858557↗
- Paper Proteomic analysis of pancreatic juice for the identification of biomarkers of pancreatic cancer. DOI 10.1007/s00432-011-0992-2↗
- Si Young Song · 3 shared papers, 2011–2017 · strength 0.14
- Paper Assessment of the Risk of Colorectal Cancer Survivors Developing a Second Primary Pancreatic Cancer. DOI 10.5009/gnl16526↗
- Paper Folfox4 as a rescue chemotherapy for gemcitabine-refractory pancreatic cancer. PMID 23858557↗
- Paper Proteomic analysis of pancreatic juice for the identification of biomarkers of pancreatic cancer. DOI 10.1007/s00432-011-0992-2↗
- Jeong Youp Park · 3 shared papers, 2011–2017 · strength 0.14
- Paper Assessment of the Risk of Colorectal Cancer Survivors Developing a Second Primary Pancreatic Cancer. DOI 10.5009/gnl16526↗
- Paper Folfox4 as a rescue chemotherapy for gemcitabine-refractory pancreatic cancer. PMID 23858557↗
- Paper Proteomic analysis of pancreatic juice for the identification of biomarkers of pancreatic cancer. DOI 10.1007/s00432-011-0992-2↗
- Seungmin Bang · 3 shared papers, 2011–2017 · strength 0.14
- Paper Assessment of the Risk of Colorectal Cancer Survivors Developing a Second Primary Pancreatic Cancer. DOI 10.5009/gnl16526↗
- Paper Folfox4 as a rescue chemotherapy for gemcitabine-refractory pancreatic cancer. PMID 23858557↗
- Paper Proteomic analysis of pancreatic juice for the identification of biomarkers of pancreatic cancer. DOI 10.1007/s00432-011-0992-2↗
- Moon Jae Chung · 2 shared papers, 2013–2017 · strength 0.12
- Jae Bock Chung · 2 shared papers, 2013–2017 · strength 0.12
- Young‐Ki Paik · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.